You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Investigational Drug Information for L-Citrulline


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug L-Citrulline?

L-Citrulline is an investigational drug.

There have been 34 clinical trials for L-Citrulline. The most recent clinical trial was a Phase 3 trial, which was initiated on October 20th 2021.

The most common disease conditions in clinical trials are Anemia, Sickle Cell, Hypertension, and Lung Injury. The leading clinical trial sponsors are Asklepion Pharmaceuticals, LLC, National Institutes of Health (NIH), and University of Mississippi Medical Center.

There are four hundred and thirty-five US patents protecting this investigational drug and zero international patents.

Recent Clinical Trials for L-Citrulline
TitleSponsorPhase
Study to Improve Deployment Related Asthma by Using L-Citrulline SupplementationNational Jewish HealthPhase 2
Study to Improve Deployment Related Asthma by Using L-Citrulline SupplementationUnited States Department of DefensePhase 2
Study to Improve Deployment Related Asthma by Using L-Citrulline SupplementationUniversity of Colorado, DenverPhase 2

See all L-Citrulline clinical trials

Clinical Trial Summary for L-Citrulline

Top disease conditions for L-Citrulline
Top clinical trial sponsors for L-Citrulline

See all L-Citrulline clinical trials

US Patents for L-Citrulline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
L-Citrulline ⤷  Subscribe Seaweed-derived cosmetic compositions Skinergistics Clinical Skin Solutions Inc. (Vancouver, CA) ⤷  Subscribe
L-Citrulline ⤷  Subscribe Therapeutic compounds and methods of use thereof GENENTECH, INC. (South San Francisco, CA) XENON PHARMACEUTICALS INC. (Burnaby, BC, CA) ⤷  Subscribe
L-Citrulline ⤷  Subscribe Methods for control of flux in metabolic pathways through enzyme relocation The Board of Trustees of the Leland Stanford Junior University (Stanford, CA) GreenLight Biosciences, Inc. (Medford, MA) ⤷  Subscribe
L-Citrulline ⤷  Subscribe Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid L'OREAL (Paris, FR) ⤷  Subscribe
L-Citrulline ⤷  Subscribe Antibodies and immunoconjugates Genentech, Inc. (South San Francisco, CA) ⤷  Subscribe
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for L-Citrulline

Drugname Country Document Number Estimated Expiration Related US Patent
L-Citrulline Australia AU2012251468 2031-05-05 ⤷  Subscribe
L-Citrulline Canada CA2835044 2031-05-05 ⤷  Subscribe
L-Citrulline Eurasian Patent Organization EA026049 2031-05-05 ⤷  Subscribe
L-Citrulline Eurasian Patent Organization EA201391634 2031-05-05 ⤷  Subscribe
L-Citrulline European Patent Office EP2705363 2031-05-05 ⤷  Subscribe
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.